London specialist clinic Santis Health has received a 2026 Global Recognition Award for combining robotic prostatectomy, real-time pathology and multidisciplinary planning in prostate cancer care.

Adding darolutamide (Nubeqa) to androgen deprivation therapy (ADT) and radiation therapy significantly improved metastasis-free survival in patients with very high-risk prostate cancer, according to ...

Robotic surgery is increasingly covered by health insurance in India, but not without complications. Despite having a high sum insured, policyholders must navigate sub-limits and exclusions that can ...

A retrospective cohort study of 124 men with biopsy Gleason 6 prostate cancer found that elevated PSA density and perineural ...

Webcast and Conference Call Information PROCEPT BioRobotics will host a conference call to discuss the third quarter 2026 financial results on Wednesday, November 4, 2026, at 4:30 p.m. Eastern Time.

What’s New On Radiotherapy of Prostate Cancer in 2026? / OncoDaily RT, prostate cancer, prostate cancer radiotherapy, ...

<?xml encoding="utf-8" ?> PROCEPT BioRobotics PRCT reported third-quarter financial results on Wednesday. The transcript from ...

Proud to Share New PROTEUS Findings on Perioperative Treatment in High-Risk Prostate Cancer / A Douglas Laird, ADT, Alberto ...

Former Bangladeshi Prime Minister Sheikh Hasina has told The Associated Press that she remains committed to returning to ...

Diagnosed in December 2022, medical professional Shailesh Pathak opted for non-surgical treatment over prostate removal due ...

The LUNAR trial assessed secondary survival endpoints in patients with oligorecurrent prostate cancer receiving 177Lu-PNT2002 and radiotherapy.

Perioperative apalutamide plus ADT and surgery lowered risk of recurrence or death by 62% in high-risk localized or locally advanced prostate cancer.